Ask AI
Case Challenge: NSCLC

CE / CME

Biomarker Testing in Patients With Solid Tumors: Interactive Case Challenge for NSCLC

Nurse Practitioners/Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Released: June 16, 2026

Expiration: December 15, 2026

Activity

Progress
1 2
Course Completed

How many people with lung cancer do you provide care for in a typical month?

Which best describes your practice setting?

A patient with which of the following actionable biomarkers would be a candidate for amivantamab plus lazertinib as their initial systemic therapy?

A patient with newly diagnosed ALK-positive metastatic NSCLC and their caregiver ask about newer long-term data for lorlatinib. Which of the following would you tell them was reported from the 7-year follow-up of the phase III CROWN trial?